Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01444924 · ClinicalTrials.gov registry record · Phase 2

Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery

A Phase 2 study of Postoperative Pain and Gynecologic Cancer, sponsored by University of Wisconsin, Madison.

Completed
Registry status
Phase 2
Development phase
75
Enrollment target
1
Study location

NCT01444924: Completed Phase 2 study of Postoperative Pain and Gynecologic Cancer, sponsored by University of Wisconsin, Madison.

NCT01444924 is a Phase 2 study of Postoperative Pain and Gynecologic Cancer that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 75 participants, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01444924, a Phase 2 study of Postoperative Pain and Gynecologic Cancer, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
Phase 2
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

This study is a single-center, randomized, placebo-controlled, double-blind clinical trial. The purpose of this study is to evaluate the impact of pre-operative transverses abdominis plane (TAP) blocks on post-operative analgesia in patients undergoing robotic surgery for gynecologic cancers.

Interventions

  • DRUG Placebo
  • DRUG Bupivicaine

Study Locations (1)

Wisconsin

  • University of Wisconsin School of Medicine and Public Health - Madison

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2011-09
Est. Completion 2013-03
Phase Phase 2
University of Wisconsin, Madison

1,039 total trials

What the finished NCT01444924 record still lists

NCT01444924 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (68% lower).

The record links to 2 conditions, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01444924 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT01444924 about?

NCT01444924 is a clinical study titled "Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery". This study is a single-center, randomized, placebo-controlled, double-blind clinical trial. The purpose of this study is to evaluate the impact of pre-operative transverses abdominis plane (TAP) blocks on post-operative analgesia in patients undergoing robotic surgery for gynecologic cancers.

What is the current status of trial NCT01444924?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2011-09. Estimated completion is 2013-03.

What conditions does trial NCT01444924 study?

This clinical trial studies the following conditions: Postoperative Pain, Gynecologic Cancer.

What interventions are being tested in trial NCT01444924?

The interventions under investigation include: Placebo (DRUG), Bupivicaine (DRUG).

Who is sponsoring clinical trial NCT01444924?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01444924 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01444924's enrollment target sits among peer trials

75 77th of 120 higher than 41 of 120 other Postoperative Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01444924, the US trial registry maintained by the National Library of Medicine. NCT01444924 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.